(Q34749066)

4 August 2017

1 reference

title

Zidovudine: a review of its use in the management of vertically-acquired pediatric HIV infection (English)

1 reference

4 August 2017

1 reference

3

Caroline M Perry

1 reference

4 August 2017

4

David P Figgitt

1 reference

4 August 2017

Nila Bhana

1

1 reference

4 August 2017

Douglas Ormrod

series ordinal

2

1 reference

4 August 2017

publication date

1 January 2002

1 reference

4 August 2017

1 reference

4 August 2017

volume

4

1 reference

4 August 2017

issue

8

1 reference

4 August 2017

page(s)

515-553

1 reference

https://scigraph.springernature.com/pub.10.2165/00128072-200204080-00004

4 August 2017

exact match

0 references

cites work

Pharmacokinetic interaction between zidovudine and trimethoprim/sulphamethoxazole in HIV-1 infected children

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00128072-200204080-00004

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00128072-200204080-00004

Treatment of human immunodeficiency virus infection and its associated complications in children

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00128072-200204080-00004

Glucuronidation of 3'-azido-3'-deoxythymidine (zidovudine) by human liver microsomes: relevance to clinical pharmacokinetic interactions with atovaquone, fluconazole, methadone, and valproic acid

21 January 2018

1 reference

12 December 2020

Effects of standard breakfast on pharmacokinetics of oral zidovudine in patients with AIDS.

1 reference

12 December 2020

Use of standardized SCID-hu Thy/Liv mouse model for preclinical efficacy testing of anti-human immunodeficiency virus type 1 compounds

1 reference

12 December 2020

Pharmacokinetics and bioavailability of zidovudine in humans

1 reference

12 December 2020

Perinatal HIV-1 transmission: interaction between zidovudine prophylaxis and mode of delivery in the French Perinatal Cohort

1 reference

12 December 2020

Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group

1 reference

12 December 2020

Effects of antiviral nucleoside analogs on human DNA polymerases and mitochondrial DNA synthesis

1 reference

12 December 2020

Current evidence for the use of paediatric antiretroviral therapy--a PENTA analysis. Paediatric European Network for the Treatment of AIDS Steering Committee.

1 reference

12 December 2020

Effects of drugs on 2',3'-dideoxy-2',3'-didehydrothymidine phosphorylation in vitro

1 reference

12 December 2020

A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators

1 reference

12 December 2020

Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

1 reference

12 December 2020

15-month efficacy of maternal oral zidovudine to decrease vertical transmission of HIV-1 in breastfed African children. DITRAME ANRS 049 Study Group

1 reference

12 December 2020

Brief report: primary infection with zidovudine-resistant human immunodeficiency virus type 1.

1 reference

12 December 2020

Trends in perinatal transmission of HIV/AIDS in the United States

1 reference

12 December 2020

Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team.

1 reference

12 December 2020

Prolonged, but not diminished, zidovudine absorption induced by a high-fat breakfast.

1 reference

12 December 2020

Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012).

1 reference

12 December 2020

Prevention of mother-to-child transmission of HIV-1 in Africa

1 reference

12 December 2020

Vertical transmission of HIV-1 in Poland

1 reference

12 December 2020

Antiretroviral resistance mutations among pregnant human immunodeficiency virus type 1-infected women and their newborns in the United States: vertical transmission and clades

1 reference

12 December 2020

The passage of azidodeoxythymidine into and within the central nervous system: does it follow the parent compound, thymidine?

1 reference

12 December 2020

A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children

1 reference

12 December 2020

Guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission.

1 reference

12 December 2020

Long-term exposure to zidovudine affects in vitro and in vivo the efficiency of phosphorylation of thymidine kinase

1 reference

12 December 2020

Reduced antiretroviral drug susceptibility among patients with primary HIV infection

1 reference

12 December 2020

The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: phase I acquired immunodeficiency syndrome clinical trials group study (protocol 082). Zidovudi

1 reference

12 December 2020

Factors predictive of maternal-fetal transmission of HIV-1. Preliminary analysis of zidovudine given during pregnancy and/or delivery

1 reference

12 December 2020

Alteration of thymidine kinase activity in cells treated with an antiviral agent

1 reference

12 December 2020

HIV-infected pregnant women and vertical transmission in Europe since 1986. European collaborative study

1 reference

12 December 2020

Pharmacokinetics of intracellular zidovudine and its phosphorylated anabolites in the absence and presence of stavudine using an in vitro human peripheral blood mononuclear cell (PBMC) model

1 reference

12 December 2020

Obstetric factors and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohorts. SEROGEST French Pediatric HIV Infection Study Group

1 reference

12 December 2020

Distinct risk factors for intrauterine and intrapartum human immunodeficiency virus transmission and consequences for disease progression in infected children. Perinatal AIDS Collaborative Transmission Study

1 reference

12 December 2020

Comparison of dual nucleoside-analogue reverse-transcriptase inhibitor regimens with and without nelfinavir in children with HIV-1 who have not previously been treated: the PENTA 5 randomised trial

1 reference

12 December 2020

Effect of zidovudine and didanosine treatment on heart function in children infected with human immunodeficiency virus

1 reference

12 December 2020

Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States (revised November 3, 2000).

1 reference

12 December 2020

Mechanisms and timing of mother-to-child transmission of HIV-1

1 reference

12 December 2020

Mitochondrial and peroxisomal dysfunction following perinatal exposure to antiretroviral drugs.

1 reference

12 December 2020

Zidovudine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy

1 reference

12 December 2020

Virological and immunological effects of treatment interruptions in HIV-1 infected patients with treatment failure

1 reference

12 December 2020

A multicenter trial of oral zidovudine in children with advanced human immunodeficiency virus disease. The Protocol 043 Study Group

1 reference

12 December 2020

Pharmacokinetics and potential interactions amongst antiretroviral agents used to treat patients with HIV infection

1 reference

12 December 2020

Variability in zidovudine serum concentrations

1 reference

12 December 2020

Nevirapine: a review of its use in the prevention and treatment of paediatric HIV infection

1 reference

12 December 2020

Antiretroviral therapy during pregnancy and the risk of an adverse outcome

1 reference

12 December 2020

Comparison of genotypic and phenotypic resistance patterns of human immunodeficiency virus type 1 isolates from patients treated with stavudine and didanosine or zidovudine and lamivudine

1 reference

12 December 2020

Lack of effect of concomitant zidovudine on rifabutin kinetics in patients with AIDS-related complex

1 reference

12 December 2020

Phase I study of low-dose zidovudine and acyclovir in asymptomatic human immunodeficiency virus seropositive individuals

1 reference

12 December 2020

Oral zidovudine during labor to prevent perinatal HIV transmission, Bangkok: tolerance and zidovudine concentration in cord blood. Bangkok Collaborative Perinatal HIV Transmission Study Group

1 reference

12 December 2020

Combination antiretroviral therapy and duration of pregnancy

1 reference

12 December 2020

Pharmacokinetic interaction between zidovudine and valproic acid in patients infected with human immunodeficiency virus

1 reference

12 December 2020

Implementing short-course zidovudine to reduce mother-infant HIV transmission in a large pilot program in Thailand

1 reference

12 December 2020

Predictive value of quantitative plasma HIV RNA and CD4+ lymphocyte count in HIV-infected infants and children

1 reference

12 December 2020

Pharmacokinetics of Zidovudine in HIV-Positive Patients with Liver Disease

1 reference

12 December 2020

Abacavir: a review of its clinical potential in patients with HIV infection

1 reference

12 December 2020

Randomized study of the tolerance and efficacy of high- versus low-dose zidovudine in human immunodeficiency virus-infected children with mild to moderate symptoms (AIDS Clinical Trials Group 128). Pediatric AIDS Clinical Trials Group.

1 reference

12 December 2020

Protease inhibitor therapy in children with perinatally acquired HIV infection

1 reference

12 December 2020

Azidothymidine (zidovudine) transport by the human placenta

1 reference

12 December 2020

Plasma and cerebrospinal fluid pharmacokinetics of 3'-azido-3'-deoxythymidine: a novel pyrimidine analog with potential application for the treatment of patients with AIDS and related diseases

1 reference

12 December 2020

Efficacy of antenatal zidovudine in reducing perinatal transmission of human immunodeficiency virus type 1. The New York City Perinatal HIV Transmission Collaborative Study Group

1 reference

12 December 2020

After AIDS clinical trial 076: the changing pattern of zidovudine use during pregnancy, and the subsequent reduction in the vertical transmission of human immunodeficiency virus in a cohort of infected women and their infants. Women and Infants Tran

1 reference

12 December 2020

Influence of prior exposure to zidovudine on stavudine phosphorylation in vivo and ex vivo

1 reference

12 December 2020

Brief Report: Trends in Antiretroviral Therapy and Mother-Infant Transmission of HIV

1 reference

12 December 2020

Efficacy of AZT therapy in reducing p24 antigen burden in a modified SCID mouse model of HIV infection

1 reference

12 December 2020

Clinical pharmacokinetics of zidovudine. An update

1 reference

12 December 2020

Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial

1 reference

12 December 2020

Mutational patterns in the HIV genome and cross-resistance following nucleoside and nucleotide analogue drug exposure

1 reference

12 December 2020

A randomized study of combined zidovudine-lamivudine versus didanosine monotherapy in children with symptomatic therapy-naive HIV-1 infection

1 reference

12 December 2020

Effect of antiretroviral combination therapy (zidovudine/didanosine or zidovudine/lamivudine) on quantitative plasma human immunodeficiency virus-ribonucleic acid in children and adolescents infected with human immunodeficiency virus

1 reference

12 December 2020

HIV-1 genotypic zidovudine drug resistance and the risk of maternal--infant transmission in the women and infants transmission study. The Women and Infants Transmission Study Group.

1 reference

12 December 2020

Selective action of 2',3'-didehydro-2',3'-dideoxythymidine triphosphate on human immunodeficiency virus reverse transcriptase and human DNA polymerases

1 reference

12 December 2020

Human immunodeficiency virus infection in children.

1 reference

12 December 2020

Codon 215 mutations in human immunodeficiency virus-infected pregnant women. Swiss Collaborative 'HIV and Pregnancy' Study

1 reference

12 December 2020

Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues

1 reference

12 December 2020

6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. DITRAME Study G

1 reference

12 December 2020

Combination antiretroviral therapy in human immunodeficiency virus-infected pregnant women

1 reference

12 December 2020

Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission.

1 reference

12 December 2020

Absorption and elimination kinetics of zidovudine in the cerebrospinal fluid in HIV-1-infected patients.

1 reference

12 December 2020

Effect of dipyridamole on zidovudine pharmacokinetics and short-term tolerance in asymptomatic human immunodeficiency virus-infected subjects

1 reference

12 December 2020

Zidovudine Therapy and HIV Type 1 Mutations in Children with Symptomatic HIV Type 1 Infection: Effect of Switching to Didanosine or Zidovudine Plus Didanosine Therapy

1 reference

12 December 2020

Pharmacokinetics and safety of oral levofloxacin in human immunodeficiency virus-infected individuals receiving concomitant zidovudine

1 reference

12 December 2020

Fluctuations in symptoms in human immunodeficiency virus-infected children: the first 10 years of life

1 reference

12 December 2020

Atovaquone inhibits the glucuronidation and increases the plasma concentrations of zidovudine

1 reference

12 December 2020

Zidovudine pharmacokinetics in premature infants exposed to human immunodeficiency virus

1 reference

12 December 2020

Zidovudine, Didanosine, or Both as the Initial Treatment for Symptomatic HIV-Infected Children

1 reference

12 December 2020

Mother-to-infant HIV transmission: timing, risk factors and prevention

1 reference

12 December 2020

Prevalence and characteristics of multinucleoside-resistant human immunodeficiency virus type 1 among European patients receiving combinations of nucleoside analogues

1 reference

12 December 2020

Reduction of 3'-azido-3'-deoxythymidine to 3'-amino-3'-deoxythymidine in human liver microsomes and its relationship to cytochrome P450

1 reference

12 December 2020

Vertical transmission of HIV-1 infection

1 reference

12 December 2020

Phase I evaluation of zidovudine administered to infants exposed at birth to the human immunodeficiency virus

1 reference

12 December 2020

Early therapy of vertical human immunodeficiency virus type 1 (HIV-1) infection: control of viral replication and absence of persistent HIV-1-specific immune responses

1 reference

12 December 2020

Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus

1 reference

12 December 2020

Zidovudine. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy

1 reference

12 December 2020

Neurological and developmental effects of HIV and AIDS in children and adolescents

1 reference

12 December 2020

Zidovudine phosphorylation in HIV-infected patients and seronegative volunteers

1 reference

12 December 2020

Prevention of vertical HIV transmission: additive protective effect of elective Cesarean section and zidovudine prophylaxis. Swiss Neonatal HIV Study Group

1 reference

12 December 2020

A phase I/II study of the protease inhibitor indinavir in children with HIV infection

1 reference

12 December 2020

Pharmacokinetic and toxicity studies of AZT (zidovudine) following perfusion of human term placenta for 14 hours

1 reference

12 December 2020

A randomized double-blind trial of the addition of lamivudine or matching placebo to current nucleoside analogue reverse transcriptase inhibitor therapy in HIV-infected children: the PENTA-4 trial. Paediatric European Network for Treatment of AIDS

1 reference

12 December 2020

Pharmacokinetics of concomitantly administered foscarnet and zidovudine for treatment of human immunodeficiency virus infection (AIDS Clinical Trials Group protocol 053)

1 reference

12 December 2020

Combination antiretroviral therapy including ritonavir in children infected with human immunodeficiency

1 reference

12 December 2020

Short courses of zidovudine and perinatal transmission of HIV

1 reference

12 December 2020

Transmission of antiretroviral-drug-resistant HIV-1 variants

1 reference

12 December 2020

Intravascular distribution of zidovudine: role of plasma proteins and whole blood components.

1 reference

12 December 2020

Virologic and immunologic response to nucleoside reverse-transcriptase inhibitor therapy among human immunodeficiency virus-infected infants and children.

1 reference

12 December 2020

Is zidovudine therapy in pregnant HIV-infected women associated with gestational age and birthweight?

1 reference

12 December 2020

Intracellular metabolism of zidovudine and stavudine in combination

1 reference

12 December 2020

Thai Red Cross zidovudine donation program to prevent vertical transmission of HIV: the effect of the modified ACTG 076 regimen

1 reference

12 December 2020

Pharmacokinetic interaction between rifampin and zidovudine

1 reference

12 December 2020

HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy

1 reference

12 December 2020

Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia.

1 reference

12 December 2020

Effect of maternal CD4 + cell count, acquired immunodeficiency syndrome, and viral load on disease progression in infants with perinatally acquired human immunodeficiency virus type 1 infection

1 reference

12 December 2020

Genotypic and phenotypic resistance under zidovudine and lamivudine therapy in human immunodeficiency virus-infected children

1 reference

12 December 2020

Combination treatment with zidovudine, didanosine, and nevirapine in infants with human immunodeficiency virus type 1 infection

1 reference

12 December 2020

Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV infection

1 reference

12 December 2020

Perinatal HIV infection and the effect of zidovudine therapy on transmission in rural and urban counties

1 reference

12 December 2020

Human placenta does not Reduce AZT (zidovudine) to 3'-amino-3'-deoxythymidine

1 reference

12 December 2020

Antiretroviral therapies in pregnancy: maternal, fetal and neonatal effects. Swiss HIV Cohort Study, the Swiss Collaborative HIV and Pregnancy Study, and the Swiss Neonatal HIV Study

1 reference

12 December 2020

Acceptability and impact of zidovudine for prevention of mother-to-child human immunodeficiency virus-1 transmission in France

1 reference

12 December 2020

Pharmacokinetics of zidovudine administered intravenously and orally in children with human immunodeficiency virus infection.

1 reference

12 December 2020

Safety of the maternal-infant zidovudine regimen utilized in the Pediatric AIDS Clinical Trial Group 076 Study

1 reference

12 December 2020

Absence of Cardiac Toxicity of Zidovudine in Infants

1 reference

12 December 2020

Clinical and virologic response to combination treatment with indinavir, zidovudine, and lamivudine in children with human immunodeficiency virus-1 infection: a multicenter study in the Netherlands. On behalf of the Dutch Study Group for Children wi

1 reference

12 December 2020

Maternal and umbilical cord serum zidovudine levels in human immunodeficiency virus infection

1 reference

12 December 2020

Effect of Combination Therapy Including Protease Inhibitors on Mortality among Children and Adolescents Infected with HIV-1

1 reference

12 December 2020

Impact of zidovudine use on risk and risk factors for perinatal transmission of HIV. Perinatal AIDS Collaborative Transmission Studies

1 reference

12 December 2020

Drug interactions with antiviral drugs

1 reference

12 December 2020

Rational approaches to resistance: nucleoside analogues

1 reference

12 December 2020

Decreased thymidine kinase levels in peripheral blood cells from HIV-seropositive individuals: implications for zidovudine metabolism.

1 reference

12 December 2020

Pharmacokinetic variability of zidovudine in HIV-infected individuals: subgroup analysis and drug interactions

1 reference

12 December 2020

Clarithromycin lowers plasma zidovudine levels in persons with human immunodeficiency virus infection.

1 reference

12 December 2020

Maternal plasma viral load, zidovudine and mother-to-child transmission of HIV-1 in Africa: DITRAME ANRS 049a trial

1 reference

12 December 2020

[Acute toxicity of zidovudine. Analysis of the literature and number of cases at the Paris Poison Control Center]

1 reference

12 December 2020

Maternal viral genotypic zidovudine resistance and infrequent failure of zidovudine therapy to prevent perinatal transmission of human immunodeficiency virus type 1 in pediatric AIDS Clinical Trials Group Protocol 076.

1 reference

12 December 2020

HIV-1 viral load and CD4 cell count in untreated children with vertically acquired asymptomatic or mild disease. Paediatric European Network for Treatment of AIDS (PENTA)

1 reference

12 December 2020

Pharmacokinetics of zidovudine in infants: a population analysis across studies

1 reference

12 December 2020

Inhibition of replication and cytopathic effect of human T cell lymphotropic virus type III/lymphadenopathy-associated virus by 3'-azido-3'-deoxythymidine in vitro

1 reference

12 December 2020

A randomized, double-blind study of triple nucleoside therapy of abacavir, lamivudine, and zidovudine versus lamivudine and zidovudine in previously treated human immunodeficiency virus type 1-infected children. The CNAA3006 Study Team

1 reference

12 December 2020

Safety of late in utero exposure to zidovudine in infants born to human immunodeficiency virus-infected mothers: Bangkok. Bangkok Collaborative Perinatal HIV Transmission Study Group

1 reference

12 December 2020

Viral load and disease progression in infants infected with human immunodeficiency virus type 1. Women and Infants Transmission Study Group

1 reference

12 December 2020

Prenatal zidovudine use and congenital anomalies in a medicaid population

1 reference

12 December 2020

Twenty-four month efficacy of a maternal short-course zidovudine regimen to prevent mother-to-child transmission of HIV-1 in West Africa

1 reference

12 December 2020

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

1 reference

12 December 2020

Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trial

1 reference

12 December 2020

British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy

1 reference

12 December 2020

The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1--a meta-analysis of 15 prospective cohort studies

1 reference

12 December 2020

Lack of tumors in infants with perinatal HIV-1 exposure and fetal/neonatal exposure to zidovudine

1 reference

12 December 2020

Long-term virologic and immunologic responses in human immunodeficiency virus type 1-infected children treated with indinavir, zidovudine, and lamivudine

1 reference

12 December 2020

Systemic pharmacokinetics and cellular pharmacology of zidovudine in human immunodeficiency virus type 1-infected women and newborn infants

1 reference

12 December 2020

Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo-controlled trial

1 reference

12 December 2020

Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy

1 reference

12 December 2020

Therapeutic and other interventions to reduce the risk of mother-to-child transmission of HIV-1 in Europe. The European Collaborative Study

1 reference

12 December 2020

Reduction in the risk of vertical transmission of HIV-1 associated with treatment of pregnant women with orally administered zidovudine alone

1 reference

12 December 2020

Rapid development of genotypic resistance to lamivudine when combined with zidovudine in pregnancy.

1 reference

12 December 2020

Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1.

1 reference

12 December 2020

Intestinal Malabsorption and Zidovudine Bioavailability

1 reference

12 December 2020

Increased ability for selection of zidovudine resistance in a distinct class of wild-type HIV-1 from drug-naive persons

1 reference

12 December 2020

A randomized comparative trial of stavudine (d4T) versus zidovudine (ZDV, AZT) in children with human immunodeficiency virus infection. AIDS Clinical Trials Group 240 Team

1 reference

12 December 2020

Clinical pharmacokinetics of 3'-azido-3'-deoxythymidine (zidovudine) and catabolites with formation of a toxic catabolite, 3'-amino-3'-deoxythymidine

1 reference

12 December 2020

Efficacy of zidovudine and human immunodeficiency virus (HIV) hyperimmune immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: results of Pediatric AIDS Clinical Trials Group protocol 185.

1 reference

12 December 2020

Pharmacokinetics of zidovudine and dideoxyinosine alone and in combination in children with HIV infection

1 reference

12 December 2020

Zidovudine and didanosine combination therapy in children with human immunodeficiency virus infection

1 reference

12 December 2020

D4T nucleoside combinations for HIV

1 reference

12 December 2020

Inhibition of human immunodeficiency virus (HIV-1/HTLV-IIIBa-L) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidine and related 2',3'-dideoxynucleosides

1 reference

12 December 2020

Effect of fluconazole on zidovudine pharmacokinetics in patients infected with human immunodeficiency virus

1 reference

12 December 2020

Enzymatic assay for measurement of zidovudine triphosphate in peripheral blood mononuclear cells

1 reference

12 December 2020

Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group

1 reference

12 December 2020

An effective and safe protocol involving zidovudine and caesarean section to reduce vertical transmission of HIV-1 infection

1 reference

12 December 2020

A fossil record of zidovudine resistance in transmitted isolates of HIV-1

1 reference

12 December 2020

Level and pattern of HIV-1-RNA viral load over age: differences between girls and boys?

1 reference

12 December 2020

Comparative pharmacokinetics of antiviral nucleoside analogues

1 reference

12 December 2020

Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway

1 reference

12 December 2020

Drug interactions with zidovudine

1 reference

12 December 2020

Evaluation of pharmacokinetics, safety, tolerance, and activity of combination of zalcitabine and zidovudine in stable, zidovudine-treated pediatric patients with human immunodeficiency virus infection. AIDS Clinical Trials Group Protocol 190 Team

1 reference

12 December 2020

Human DNA polymerases alpha and beta are able to incorporate anti-HIV deoxynucleotides into DNA

1 reference

12 December 2020

Nucleoside analogs plus ritonavir in stable antiretroviral therapy-experienced HIV-infected children: a randomized controlled trial. Pediatric AIDS Clinical Trials Group 338 Study Team

1 reference

12 December 2020

Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams.

1 reference

12 December 2020

Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV-1 infection. Italian Register for HIV Infection in Children and the Italian National AIDS Registry

1 reference

12 December 2020

In vivo antagonism with zidovudine plus stavudine combination therapy

1 reference

12 December 2020

Nucleoside exposure in the children of HIV-infected women receiving antiretroviral drugs: absence of clear evidence for mitochondrial disease in children who died before 5 years of age in five United States cohorts

1 reference

12 December 2020

Pilot study of zidovudine-lamivudine combination therapy in vertically HIV-infected antiretroviral-naive children

1 reference

12 December 2020

Early prognostic indicators in primary perinatal human immunodeficiency virus type 1 infection: importance of viral RNA and the timing of transmission on long-term outcome

1 reference

12 December 2020

Recommendations of the U.S. Public Health Service Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus

1 reference

12 December 2020

Prevention of mother-infant HIV transmission. Thailand, 1998-2000. Part I

1 reference

12 December 2020

Zidovudine phosphorylation and mitochondrial toxicity in vitro

1 reference

12 December 2020

10.2165/00128072-200204080-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

4 August 2017

1050193061

0 references

1 reference